Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study

Eitemau Tebyg

• The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
  gan: Ali, M, et al.
  Cyhoeddwyd: (2018)
• The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
  gan: Robinson, D, et al.
  Cyhoeddwyd: (2018)
• Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
  gan: Robinson, DE, et al.
  Cyhoeddwyd: (2021)
• Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
  gan: Robinson, DE, et al.
  Cyhoeddwyd: (2021)
• Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
  gan: Robinson, DE, et al.
  Cyhoeddwyd: (2021)